Ariad Pharmaceuticals

Ariad Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary platform technologies and therapeutic products based on gene regulation and signal transduction. The Company has two primary programs, regulated gene therapy and signal transduction inhibitors, which directly capitalize on its core competencies. The Company's proprietary gene regulation technologies, referred to as Argent and Rapid, provide alternatives to conventional approaches to gene therapy, in which a gene is introduced into the body with no way to turn it off or to modulate its level of activity. The Company's gene therapy allows genes and proteins to be precisely controlled, enabling physicians to maintain protein levels within desired therapeutic ranges; its signal transduction inhibitor program capitalizes on the discovery of signaling proteins encoded by genes, including those identified through the human genome project.

Previous Forums
Date/Time		Forum
Nov 8 2000		Techvest's Second Annual Conference on Tissue Repair, Replacement and Regeneration - Day 1

Market Assistant		PrecisionAlert
This company has no data		Enter your email address to receive alerts about this company